G-CSF, a growth factor that stimulates neutrophils, has been shown to decrease morbidity and mortality from infections in randomized controlled trials when used prophylactically after chemotherapy [60–62] and may enhance the clearance of influenza virus infection by neutrophil-mediated guidance and maintenance of CD8+ T cells [31, 32]. This evidence concerns the gene CD8A and infection.